MedLink Neurology Home

Your First Place To Look™ for authoritative, in-depth articles covering the full spectrum of neurology!

Resource Centers

Behavioral & Cognitive Disorders
Childhood Degenerative & Metabolic Disorders
Developmental Malformations
Epilepsy & Seizures
Headaches & Pain
Infectious Disorders
Miscellaneous Neurology Disorders
Miscellaneous Pediatric Neurology Disorders
Movement Disorders
Neuro-Oncology
Neuro-Ophthalmology & Neuro-Otology
Neuroimmunology
Neuromuscular Disorders
Peripheral Neuropathies
Sleep Disorders
Stroke & Vascular Disorders

Recently Published Articles

Zonisamide
Vaccines for neurologic disorders
Unruptured cerebral aneurysms
Trichinosis
Transcranial magnetic stimulation

Site Overview - Key Features


Articles
1,200 continually-updated authoritative clinical reviews covering the entire spectrum of neurology.
Images and Videos
Nearly 3,000 illustrations, including video clips of neurologic disorders.
CME Information
Earn AMA PRA Category 1™ CME credits for routinely using MedLink Neurology.
Editorial Board
Distinguished Editorial Board and hundreds of expert authors.
External Resources
The world’s largest annotated directory of useful resources for neurologists.
Forum
Interact with your colleagues. Your privacy is protected.
Patient Handouts
Information for patients you can print or email when needed.
News
See what’s being published in the neurology and neuroscience literature.
Learn More

Editorial Board

Editor-In-Chief
Raymond P Roos MD, Editor-in-Chief, is the Marjorie and Robert E Straus Professor of Neurology at the University of Chicago and Associate Chair for Education for the Department of Neurology at University of Chicago Medical Center. Dr. Roos is solely responsible for all aspects of planning of educational activities and has ultimate responsibility for educational content.
Associate Editors
View the complete Editorial Board here.

Financial Disclosures

Dr. Raymond Roos, Editor-in-Chief
Dr. Roos serves on the Scientific Advisory Board of Revalesio Corporation, the Data and Safety Monitoring Board for a clinical trial of a Mallinckrodt Pharmaceuticals product, has received consulting fees from M-T Pharmacy and Best Doctors, and holds shares in Amgen, Merck, Ionis, and GE.
Associate Editors
Associate Editors are responsible for recruiting authors and editing all educational content. Their financial disclosures are displayed ahead of specific educational pieces for which they are responsible. Their financial disclosures are also displayed here.
Authors
Authors are responsible for researching topics assigned to them by an associate editor and writing or updating manuscripts. Their financial disclosures are displayed ahead of specific educational pieces for which they are responsible.
MedLink Corporation
MedLink Corporation does not control educational content. Nevertheless, it does not accept financial support from commercial interests, and none of its managers or other personnel have financial connections with commercial interests.

CME Information


MedLink Corporation is accredited by the ACCME to provide continuing medical education for physicians. Learn more.

Selected News

New screening tool could help diagnose early cognitive decline in dementia from home
Scientists develop new way to screen for age-related cognitive decline at home using a test which asks people to detect sounds and flashes on their laptop or phone.
Absence epilepsy—When the brain is like ‘an orchestra without a conductor’

Neurology Meetings

Neurology Meetings
A list of U.S. and international meetings, conferences, and symposiums of interest to neurologists.

Learn More About MedLink Neurology